The Role of Fgf2 and Fgfbp1 in Cerebrovascular Response to Angiotensin Ii with Renal Ischemia-Reperfusion Injury in Mice

Liang Zhao,Xiaoyun Cao,Suhan Zhou,Qin Wang,Lingli Li,Jingwei Zhao,Juan Saavedra,Christopher S. Wilcox,Anton Wellstein,En Yin Lai

DOI: https://doi.org/10.1096/fasebj.31.1_supplement.836.6

2017-01-01

Abstract:Acute kidney injury (AKI) is defined as an abrupt deterioration in kidney function. Recent studies indicate that the prevalence of AKI is relatively high and associated with poor clinical outcomes including failure of other organs that include strokes. However, the effects of AKI on cerebrovascular function is poorly understood. Here we tested the hypothesis that AKI may promote strokes by cerebrovascular sensitization to angiotensin II (Ang II) in conjunction with FGF2 (fibroblast growth factor 2) plus the secreted FGF binding protein FGFBP1. Renal ischemia‐reperfusion (I/R) mice served as the AKI model and sham‐operated mice as controls. Brain medulla oblongata arterioles were dissected and microperfused. Also, brain basal and posterior communicating arteries were dissected and tested by vascular myography. We found that the effects of the vasoconstrictors endothelin 1 or norepinephrine were not impacted in the AKI model but observed that the effects of Ang II on cerebral arterioles and arteries were enhanced. Ang II effects were further amplified by treatment with FGF2 plus FGFBP1. Complementary to this, the FGF receptor (FGFR) kinase inhibitor PD173074 decreased the cerebrovascular response to Ang II indicating a crosstalk between Ang II and the FGFR pathway. Interestingly, Ang II type 2 receptor mRNA expression in isolated cerebral vessels was reduced in AKI model relative to controls. We conclude that synergism between the FGFR and Ang II pathway increases the brain vessel response to Ang II and this enhancement of the cerebral vascular responses may be due to the reduced expression of Ang II type 2 receptor.